Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities

v3.24.3
Accrued expenses and other current liabilities
9 Months Ended
Sep. 30, 2024
Accrued expenses and other current liabilities  
Accrued expenses and other current liabilities

Note 10 Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

September 30, 

December 31, 

    

2024

    

2023

Accrued clinical and development expenditure

$

13,281

$

12,351

Accrued employee expenses

11,276

13,226

VAT payable

1,398

Other accrued expenditure

5,780

3,277

Other

 

1,167

 

51

$

31,504

$

30,303